The World Health Organization (WHO) recently released, “Global Report On Access To Hepatitis C Treatment: Focus On Overcoming Barriers,” a comprehensive report on the cost of hepatitis C (HCV) therapies and strategies employed by countries at different economic levels to reduce costs. This is the first-ever global report on treatment access to hepatitis C medicines, and it provides the information countries and health authorities need to identify the appropriate HCV treatment and procure it at affordable prices. The report uses the experience of several pioneering countries to demonstrate how barriers to treatment access can be overcome. It also provides information on the production of new hepatitis C drugs and generic versions worldwide, including where the drugs are registered, where the drugs are patented and where not, and what opportunities countries have under the license agreements that were signed by some companies.
Read the news release and the full report.
